Indacaterol/glycopyrronium versus salmeterol/fluticasone in the prevention of clinically important deterioration in COPD: results from the FLAME study. (2018)

First Author: Anzueto AR

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12931-018-0830-z

PubMed Identifier: 29925383

Publication URI: http://europepmc.org/abstract/MED/29925383

Type: Journal Article/Review

Volume: 19

Parent Publication: Respiratory research

Issue: 1

ISSN: 1465-9921